bucindolol has been researched along with Myocardial Infarction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Remme, WJ | 1 |
| Ball, S; Berning, J; Brendorp, B; Carlsen, J; Eberle, S; Hall, A; Hampton, J; Jensen, G; Køber, L; Ottesen, M; Torp-Pedersen, C; Zilles, P | 1 |
| Deedwania, P; Fagerberg, B; Ghali, J; Goldstein, S; Gottlieb, S; Hjalmarson, A; Kjekshus, J; Waagstein, F; Wedel, H; Wikstrand, J | 1 |
| Akman, D; Ali, I; Brendorp, B; Bruun, NE; Køber, L; Møller, J; Ottesen, M; Torp-Pedersen, C | 1 |
| Anand, I; Anderson, JL; Bourque, JM; Carson, P; Gottlieb, S; Krause-Steinrauf, H; O'Connor, CM; Plehn, JF; Silver, MA; White, M | 1 |
3 trial(s) available for bucindolol and Myocardial Infarction
| Article | Year |
|---|---|
The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Importance of a history of hypertension for the prognosis after acute myocardial infarction--for the Bucindolol Evaluation in Acute myocardial infarction Trial (BEAT) study group.
Topics: Adult; Aged; Aged, 80 and over; Denmark; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Propanolamines; Registries; Retrospective Studies; Risk Factors; Survival Rate; Vasodilator Agents | 2004 |
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
Topics: Adrenergic beta-Antagonists; Aged; Cause of Death; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Propanolamines; Proportional Hazards Models; Risk Factors; Survival Analysis; Treatment Outcome | 2005 |
2 other study(ies) available for bucindolol and Myocardial Infarction
| Article | Year |
|---|---|
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Topics: Adrenergic beta-Antagonists; Black People; Diabetic Angiopathies; Heart Failure; Humans; Hypertension; Meta-Analysis as Topic; Metoprolol; Multicenter Studies as Topic; Myocardial Infarction; Practice Patterns, Physicians'; Propanolamines; Randomized Controlled Trials as Topic | 2003 |